Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Goat Polyclonal Anti-CD45 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 1,260 aa to the C-terminus of human CD45 produced in E. coli. |
Goat Polyclonal Anti-CD19 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide within residues 510 aa to the C-terminus of human CD19 produced in E. coli. |
Goat Polyclonal Anti-CD4 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within 50 to 235 aa, corresponding to the external domain of human CD4 produced in E. coli. |
Goat Polyclonal Anti-CD31 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide within residues 690 aa to the C-terminus of human CD31 produced in E. coli. |
Goat Polyclonal Anti-CDH1 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified Recombinant peptide derived from within residues 601 to 701 of human CDH1 produced in E. coli. |
Goat Polyclonal Anti-CDH1 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 750 to 850 of human CDH1 produced in E. coli. |
Goat Polyclonal Anti-ERBB2 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 1,177 aa to the C-terminus of human ERBB2 produced in E. coli. |
Goat Polyclonal Anti-STX6 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 100 aa to the N-terminus of human STX6 produced in E. coli. |
Goat Polyclonal Anti-CD19 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide within residues 510 aa to the C-terminus of human CD19 produced in E. coli. |
Goat Polyclonal Anti-CD45 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 1,260 aa to the C-terminus of human CD45 produced in E. coli. |
Goat Polyclonal Anti-ERBB1 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 1,162 aa to the C-terminus of human ERBB1 produced in E. coli. |
Goat Polyclonal Anti-TNF alpha Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant human TNF-_ produced in E. coli. |
Goat Polyclonal Anti-INSR Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide within residues 1310 aa to the C-terminus of human INSR produced in E. coli. |
Goat Polyclonal Anti-CD2 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant peptide derived from within residues 300 aa to the C-terminus of human CD2 produced in E. coli. |
Active filters
Category
-
Antibodies
- Primary Antibodies
Reactivities
- Monkey
Antibody Hosts
- Goat
Isotypes
- IgG
Conjugates
- Unconjugated
Families
- Transmembrane
Availabilities
- In Stock
Filter by
Target Symbol
Clonalities
Pathways
- Cell adhesion molecules (CAMs) (8)
- Adherens junction (5)
- Hematopoietic cell lineage (5)
- Pathways in cancer (5)
- Primary immunodeficiency (5)
- Antigen processing and presentation (4)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (4)
- Bladder cancer (4)
- Endometrial cancer (4)
- Gap junction (4)
- T cell receptor signaling pathway (4)
- Melanoma (3)
- Amyotrophic lateral sclerosis (ALS) (2)
- Apoptosis (2)
- B cell receptor signaling pathway (2)
- Calcium signaling pathway (2)
- Colorectal cancer (2)
- Cytokine-cytokine receptor interaction (2)
- ErbB signaling pathway (2)
- Fc gamma R-mediated phagocytosis (2)
- Focal adhesion (2)
- Lysosome (2)
- MAPK signaling pathway (2)
- Non-small cell lung cancer (2)
- Pancreatic cancer (2)
- Pathogenic Escherichia coli infection (2)
- Prostate cancer (2)
- Thyroid cancer (2)
- Type II diabetes mellitus (2)
- Adipocytokine signaling pathway (1)
- Allograft rejection (1)
- Alzheimer's disease (1)
- Asthma (1)
- Dilated cardiomyopathy (1)
- Dorso-ventral axis formation (1)
- Endocytosis (1)
- Epithelial cell signaling in Helicobacter pylori infection (1)
- Fc epsilon RI signaling pathway (1)
- Glioma (1)
- GnRH signaling pathway (1)
- Graft-versus-host disease (1)
- Huntington's disease (1)
- Hypertrophic cardiomyopathy (HCM) (1)
- Insulin signaling pathway (1)
- Leukocyte transendothelial migration (1)
- NOD-like receptor signaling pathway (1)
- Natural killer cell mediated cytotoxicity (1)
- Neurotrophin signaling pathway (1)
- Prion diseases (1)
- RIG-I-like receptor signaling pathway (1)
- Regulation of actin cytoskeleton (1)
- SNARE interactions in vesicular transport (1)
- Systemic lupus erythematosus (1)
- TGF-beta signaling pathway (1)
- Toll-like receptor signaling pathway (1)
- Type I diabetes mellitus (1)
- p53 signaling pathway (1)